Henriette J Scherpbier

Summary

Affiliation: Academic Medical Center
Country: The Netherlands

Publications

  1. ncbi request reprint Liver failure in a child receiving highly active antiretroviral therapy and voriconazole
    Henriette J Scherpbier
    Emma Children s Hospital, Academic Medical Centre, Amsterdam, The Netherlands
    Clin Infect Dis 37:828-30. 2003
  2. ncbi request reprint Long-term experience with combination antiretroviral therapy that contains nelfinavir for up to 7 years in a pediatric cohort
    Henriette J Scherpbier
    Emma Children s Hospital, Academic Medical Center, Amsterdam, The Netherlands
    Pediatrics 117:e528-36. 2006
  3. ncbi request reprint Once-daily highly active antiretroviral therapy for HIV-infected children: safety and efficacy of an efavirenz-containing regimen
    Henriette J Scherpbier
    Emma Children s Hospital, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
    Pediatrics 119:e705-15. 2007
  4. ncbi request reprint A pharmacokinetic and pharmacogenetic study of efavirenz in children: dosing guidelines can result in subtherapeutic concentrations
    Rob ter Heine
    Department of Pharmacy and Pharmacology, Slotervaart Hospital, Amsterdam, The Netherlands
    Antivir Ther 13:779-87. 2008
  5. ncbi request reprint Population pharmacokinetics and pharmacodynamics of nelfinavir and its active metabolite M8 in HIV-1-infected children
    Kristel M L Crommentuyn
    Department of Pharmacy and Pharmacology, Slotervaart Hospital, Amsterdam, The Netherlands
    Pediatr Infect Dis J 25:538-43. 2006
  6. ncbi request reprint Viral dynamics after starting first-line HAART in HIV-1-infected children
    Vincent Bekker
    Emma Children s Hospital, Academic Medical Center, The Netherlands
    AIDS 20:517-23. 2006
  7. ncbi request reprint The pharmacokinetics of nelfinavir in HIV-1-infected children
    Rolf P G van Heeswijk
    Dept of Pharmacy and Pharmacology, Slotervaart Hospital, Amsterdam, The Netherlands
    Ther Drug Monit 24:487-91. 2002
  8. ncbi request reprint Haematological parameters of HIV-1-uninfected infants born to HIV-1-infected mothers
    Madeleine J Bunders
    Department of Paediatric Haematology, Immunology and Infectious Diseases, Emma Children s Hospital, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands
    Acta Paediatr 94:1571-7. 2005
  9. pmc Neurologic abnormalities in HIV-1 infected children in the era of combination antiretroviral therapy
    Lotus A van Arnhem
    Department of Pediatric Hematology, Immunology and Infectious Diseases, Emma Children s Hospital, Academic Medical Centre AMC, Amsterdam, The Netherlands
    PLoS ONE 8:e64398. 2013
  10. doi request reprint Mannose-binding lectin and the risk of HIV transmission and disease progression in children: a systematic review
    Joël Israëls
    Department of Pediatric Immunology, Hematology and Infectiology, Emma Children s Hospital, Academic Medical Centre, H7 228, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
    Pediatr Infect Dis J 31:1272-8. 2012

Collaborators

Detail Information

Publications11

  1. ncbi request reprint Liver failure in a child receiving highly active antiretroviral therapy and voriconazole
    Henriette J Scherpbier
    Emma Children s Hospital, Academic Medical Centre, Amsterdam, The Netherlands
    Clin Infect Dis 37:828-30. 2003
    ..We describe a 10-year-old child with vertically transmitted acquired immunodeficiency syndrome who was receiving antiretroviral combination therapy and died of liver failure after beginning voriconazole therapy...
  2. ncbi request reprint Long-term experience with combination antiretroviral therapy that contains nelfinavir for up to 7 years in a pediatric cohort
    Henriette J Scherpbier
    Emma Children s Hospital, Academic Medical Center, Amsterdam, The Netherlands
    Pediatrics 117:e528-36. 2006
    ..We sought to provide long-term data on the clinical, immunologic, and virologic response to highly active antiretroviral therapy in infants and children who are naive to protease inhibitors...
  3. ncbi request reprint Once-daily highly active antiretroviral therapy for HIV-infected children: safety and efficacy of an efavirenz-containing regimen
    Henriette J Scherpbier
    Emma Children s Hospital, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
    Pediatrics 119:e705-15. 2007
    ....
  4. ncbi request reprint A pharmacokinetic and pharmacogenetic study of efavirenz in children: dosing guidelines can result in subtherapeutic concentrations
    Rob ter Heine
    Department of Pharmacy and Pharmacology, Slotervaart Hospital, Amsterdam, The Netherlands
    Antivir Ther 13:779-87. 2008
    ..Our main objectives were to study the population pharmacokinetics of efavirenz and to explore the adequacy of dosing guidelines...
  5. ncbi request reprint Population pharmacokinetics and pharmacodynamics of nelfinavir and its active metabolite M8 in HIV-1-infected children
    Kristel M L Crommentuyn
    Department of Pharmacy and Pharmacology, Slotervaart Hospital, Amsterdam, The Netherlands
    Pediatr Infect Dis J 25:538-43. 2006
    ....
  6. ncbi request reprint Viral dynamics after starting first-line HAART in HIV-1-infected children
    Vincent Bekker
    Emma Children s Hospital, Academic Medical Center, The Netherlands
    AIDS 20:517-23. 2006
    ..Therefore viral decay and time to reach a pVL of < 400 copies/ml during the first weeks after starting HAART were studied in a cohort of HIV-1-infected children...
  7. ncbi request reprint The pharmacokinetics of nelfinavir in HIV-1-infected children
    Rolf P G van Heeswijk
    Dept of Pharmacy and Pharmacology, Slotervaart Hospital, Amsterdam, The Netherlands
    Ther Drug Monit 24:487-91. 2002
    ..However, due to a large interpatient variability in the exposure, individual dosage adjustments based on plasma concentrations may be necessary for both dosing regimens to ensure optimal treatment...
  8. ncbi request reprint Haematological parameters of HIV-1-uninfected infants born to HIV-1-infected mothers
    Madeleine J Bunders
    Department of Paediatric Haematology, Immunology and Infectious Diseases, Emma Children s Hospital, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands
    Acta Paediatr 94:1571-7. 2005
    ..To investigate haematological parameters in infants born to HIV-1-infected mothers and exposed to combination antiretroviral therapy (ART) used to prevent mother-to-child transmission (MTCT)...
  9. pmc Neurologic abnormalities in HIV-1 infected children in the era of combination antiretroviral therapy
    Lotus A van Arnhem
    Department of Pediatric Hematology, Immunology and Infectious Diseases, Emma Children s Hospital, Academic Medical Centre AMC, Amsterdam, The Netherlands
    PLoS ONE 8:e64398. 2013
    ..In recent years, the neurological outcome of HIV-1 infected children has substantially improved with combination antiretroviral therapy (cART). However, data regarding the long-term effect of cART and neurologic outcome are limited...
  10. doi request reprint Mannose-binding lectin and the risk of HIV transmission and disease progression in children: a systematic review
    Joël Israëls
    Department of Pediatric Immunology, Hematology and Infectiology, Emma Children s Hospital, Academic Medical Centre, H7 228, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
    Pediatr Infect Dis J 31:1272-8. 2012
    ..It is unclear whether genetically determined MBL deficiency is related to vertical HIV transmission and disease progression in HIV-infected children...
  11. doi request reprint Bone mineral density increases in HIV-infected children treated with long-term combination antiretroviral therapy
    Madeleine J Bunders
    Department of Paediatric Immunology, Haematology, and Infectious Diseases, Emma Children Hospital, Amsterdam, The Netherlands
    Clin Infect Dis 56:583-6. 2013
    ..Longitudinal data on bone mineral density (BMD) in HIV-infected children showed that cumulative treatment with cART had a positive impact on BMD over time...